Cambridge Cognition Holdings Plc (LON:COG – Get Free Report)’s share price crossed below its 200-day moving average during trading on Friday . The stock has a 200-day moving average of GBX 41.55 ($0.54) and traded as low as GBX 28.06 ($0.36). Cambridge Cognition shares last traded at GBX 28.50 ($0.37), with a volume of 53,821 shares changing hands.
Cambridge Cognition Stock Performance
The company has a market cap of £11.95 million, a PE ratio of -712.50 and a beta of 0.72. The company has a debt-to-equity ratio of 92.53, a current ratio of 0.65 and a quick ratio of 0.96. The business has a 50-day moving average of GBX 36.16 and a 200 day moving average of GBX 41.31.
Cambridge Cognition Company Profile
Cambridge Cognition Holdings Plc, a neuroscience technology company, develops and markets near-patient cognitive testing techniques in the United States, United Kingdom, the European Union, and internationally. The company offers CANTAB digital cognitive assessment platform for drug development by enabling pharmaceutical companies to take new therapeutics from preclinical consultancy to pivotal studies and approval, as well as supports sponsors to enhance recruitment, develop safe and effective treatments, and enhance research and development efficiency.
Featured Stories
- Five stocks we like better than Cambridge Cognition
- Asset Allocation: The Key to a Successful Portfolio. Are You Paying Attention to Yours?
- From PACs to Portfolios: Billionaire Bets and Investor Reactions
- How to Invest in the Best Canadian Stocks
- AppLovin Stock Quadruples: What’s Behind the Bullish Sentiment?
- The 3 Best Blue-Chip Stocks to Buy Now
- Battle of the Retailers: Who Comes Out on Top?
Receive News & Ratings for Cambridge Cognition Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cambridge Cognition and related companies with MarketBeat.com's FREE daily email newsletter.
